Trial intelligence / Profile preview

ARQ 501 in advanced squamous cell carcinoma of the head and neck

NCT00358930Phase 2Completed

Start
Jul 2006
Primary completion
Aug 2007
Countries
1
01

Overview

A Phase 2 trial of lapachone in squamous cell carcinoma of the head and neck (HNSCC). Started Jul 2006; status: completed.

02

Drugs

lapachone
03

Conditions

squamous cell carcinoma of the head and neck (HNSCC)

Beyond the preview

Go deeper on NCT00358930.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00358930.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call